Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Precigen
Biotech
Precigen laying off staff to eke out cash for approval filing
Precigen is laying off 20% of its employees and pausing a raft of programs to focus its limited funds on bringing a gene therapy to market.
Nick Paul Taylor
Aug 7, 2024 5:46am
New year, new name, new CEO for synthetic biology co. Intrexon
Jan 3, 2020 10:38am
Ziopharm cuts Precigen ties, narrowing its R&D focus
Oct 10, 2018 11:05am
Change in direction at Intrexon has Germano heading for the exit
Mar 13, 2017 9:29am